GENEVA, July 27 -- ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. filed a patent application (US2026/011240) for “CHIMERIC ANTIGEN RECEPTORS TARGETING CLUSTER OF DIFFERENTIATION 19 (CD19) AND CLUSTER OF DIFFERENTIATION 22 (CD22)”. With publication no. WO/2026/156062, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 40/11
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....